Efficacy of a Novel Intraoperative Surgical Irrigant in Preventing Periprosthetic Joint Infections in Primary Knee, Hip, and Shoulder Arthroplasties: A Retrospective Analysis

Abstract

Objective: Primary joint arthroplasty (JA) is one of the most common operating room (OR) procedures, with knee and hip arthroplasties being listed in the top five most frequent OR procedures and while not as common, shoulder arthroplasties are increasing at greater rates than knee and hip arthroplasties. Periprosthetic joint/shoulder infections (PJI/PSI) are a devastating complication of primary JAs with infection prevention deemed as the single most important strategy in combating them. The objective of this study was to retrospectively evaluate the efficacy of XPERIENCE® Advanced Surgical Irrigation (XP) in preventing PJI following primary joint arthroplasty.

Methods: This is a retrospective study of primary knee, hip and shoulder arthroplasties that were performed by multiple orthopedic surgeons at a single hospital setting. XPERIENCE was used as an intraoperative surgical irrigant either solely, or with other intraoperative practices for prevention of infection. Incidence of acute PJI occurring within 90 days of index surgery were retrospectively collated.

Results: Four hundred and twenty-three (423) primary joint replacement surgeries treated intraoperatively with XP, were evaluated for acute PJI incidence. Retrospective evaluations determined that 95% of the subjects had at least one risk factor predisposing them to PJI. There were zero PJIs diagnosed in the knee and hip arthroplasty cohorts and zero PSIs diagnosed in the shoulder arthroplasty cohorts.

Conclusion: The absence of PJI/PSI diagnoses in the JA cohorts treated intraoperatively with XP indicates that it could be an efficacious antimicrobial irrigant in preventing PJI, and warrants being evaluated in prospective, randomized controlled clinical trials as the sole intraoperative irrigant, as well as in combination with the other intraoperative infection prevention regimens evaluated in this retrospective study.

Keywords

Biofilm / Intraoperative irrigant / Periprosthetic joint infection / Primary joint arthroplasty / Retrospective study

References

[1] McDermottKW, LiangL. Overview of operating room procedures during inpatient stays in U.S. hospitals, 2018. Healthcare cost and utilization project (HCUP) statistical briefs. Rockville, MD: Agency for Healthcare Research and Quality (US); 2006 Available from: http://www.ncbi.nlm.nih.gov/books/NBK574416/

[2] SinghJA, YuS, ChenL, Cleveland JD. Rates of total joint replacement in the United States: future projections to 2020–2040 using the national inpatient sample. J Rheumatol. 2019;46(9):1134–1140.

[3] WagnerER, FarleyKX, HigginsI, Wilson JM, DalyCA, GottschalkMB. The incidence of shoulder arthroplasty: rise and future projections compared with hip and knee arthroplasty. J Shoulder Elbow Surg. 2020;29(12):2601–2609.

[4] PremkumarA, KolinDA, FarleyKX, Wilson JM, McLawhornAS, CrossMB, et al. Projected economic burden of periprosthetic joint infection of the hip and knee in the United States. J Arthroplasty. 2021;36(5):1484–1489.e3.

[5] SchickS, Elphingstone J, MuraliS, CarterK, DavisW, McGwinG, et al. The incidence of shoulder arthroplasty infection presents a substantial economic burden in the United States: a predictive model. JSES Int. 2023;7(4):636–641.

[6] TarabichiS, Parvizi J. Prevention of surgical site infection: a ten-step approach. Art Ther. 2023;5(1):21.

[7] DobsonPF, ReedMR. Prevention of infection in primary THA and TKA. EFORT Open Rev. 2020;5(10):604–613.

[8] SSI | PSC | NHSN | CDC. 2023 [cited 2023 Mar 17]. Available from: https://www.cdc.gov/nhsn/psc/ssi/index.html

[9] ParviziJ, TanTL, GoswamiK, Higuera C, Della ValleC, ChenAF, et al. The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. J Arthroplasty. 2018;33(5):1309–1314.e2.

[10] GarriguesGE, Zmistowski B, CooperAM, GreenA, ICM Shoulder Group. Proceedings from the 2018 international consensus meeting on orthopedic infections: the definition of periprosthetic shoulder infection. J Shoulder Elbow Surg. 2019;28(6):S8–S12.

[11] TubbCC, Polkowksi GG, KrauseB. Diagnosis and prevention of periprosthetic joint infections. J Am Acad Orthop Surg. 2020;28(8):e340–e348.

[12] ZardiEM, Franceschi F. Prosthetic joint infection. A relevant public health issue. J Infect Public Health. 2020;13(12):1888–1891.

[13] Marang-van De MheenPJ, Bragan TurnerE, LiewS, MutalimaN, Tran T, RasmussenS, et al. Variation in prosthetic joint infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals. BMC Musculoskelet Disord. 2017;18(1):207.

[14] KapadiaBH, BergRA, DaleyJA, Fritz J, BhaveA, MontMA. Periprosthetic joint infection. Lancet. 2016;387(10016):386–394.

[15] JaureguiJJ, TranA, KaveeshwarS, Nadarajah V, ChaudhriMW, HennRF, et al. Diagnosing a periprosthetic shoulder infection: a systematic review. J Orthop. 2021;26:58–66.

[16] BonnevialleN, Dauzères F, ToulemondeJ, EliaF, Laffosse JM, MansatP. Periprosthetic shoulder infection: an overview. EFORT Open Rev. 2017;2(4):104–109.

[17] NIH guide: research on microbial biofilms. [cited 2023 Mar 21]. Available from: https://grants.nih.gov/grants/guide/pa-files/pa-03-047.html

[18] VestbyLK, Grønseth T, SimmR, NesseLL. Bacterial biofilm and its role in the pathogenesis of disease. Antibiotics. 2020;9(2):59.

[19] GbejuadeHO, Lovering AM, WebbJC. The role of microbial biofilms in prosthetic joint infections: a review. Acta Orthop. 2015;86(2):147–158.

[20] KhatoonZ, McTiernan CD, SuuronenEJ, MahTF, Alarcon EI. Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention. Heliyon. 2018;4(12):e01067.

[21] FinkB, Sevelda F. Periprosthetic joint infection of shoulder arthroplasties: diagnostic and treatment options. Biomed Res Int. 2017;2017:1–10.

[22] StewartPS, Bjarnsholt T. Risk factors for chronic biofilm-related infection associated with implanted medical devices. Clin Microbiol Infect. 2020;26(8):1034–1038.

[23] Rodríguez-MerchánEC, DavidsonDJ, LiddleAD. Recent strategies to combat infections from biofilm-forming bacteria on orthopaedic implants. IJMS. 2021;22(19):10243.

[24] KhanJ, TararSM, GulI, NawazU, ArshadM. Challenges of antibiotic resistance biofilms and potential combating strategies: a review. 3 Biotech. 2021;11(4):169.

[25] GonzálezJF, Hahn MM, GunnJS. Chronic biofilm-based infections: skewing of the immune response. Pathog Dis. 2018;76(3):1–7.

[26] KruckenhauserEM, NoglerM, Coraça-HuberD. Use of lavage fluids in arthroplasty to prevent postoperative infections. Drug Res (Stuttg). 2013;64(3):166–168.

[27] BrownNM, Cipriano CA, MoricM, SporerSM, Della Valle CJ. Dilute betadine lavage before closure for the prevention of acute postoperative deep periprosthetic joint infection. J Arthroplasty. 2012;27(1):27–30.

[28] FrischNB, KadriOM, TenbrunselT, Abdul-Hak A, QatuM, DavisJJ. Intraoperative chlorhexidine irrigation to prevent infection in total hip and knee arthroplasty. Arthroplasty Today. 2017;3(4):294–297.

[29] NormanG, Atkinson RA, SmithTA, RowlandsC, Rithalia AD, CrosbieEJ, et al. Intracavity lavage and wound irrigation for prevention of surgical site infection. Cochrane Database Syst Rev. 2017;10(10):CD012234.

[30] Next Science. Biofilm and antibiotic resistance solutions. Available from: https://www.nextscience.com/technology/

[31] BashyalRK, MathewM, BowenE, James GA, StulbergSD. A novel irrigant to eliminate planktonic bacteria and eradicate biofilm superstructure with persistent effect during total hip arthroplasty. J Arthroplasty. 2022;37(7S):S647–S652.

[32] ParvinF, Vickery K, DevaAK, HuH. Efficacy of surgical/wound washes against bacteria: effect of different in vitro models. Materials (Basel). 2022;15(10):3630.

[33] Berríos-TorresSI, UmscheidCA, Bratzler DW, LeasB, StoneEC, KelzRR, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152(8):784–791.

[34] Global guidelines for the prevention of surgical site infection. Geneva: World Health Organization; 2018 Available from: http://www.ncbi.nlm.nih.gov/books/NBK536404/

[35] GoswamiK, AustinMS. Intraoperative povidone-iodine irrigation for infection prevention. Arthroplast Today. 2019;5(3):306–308.

[36] ChengB, OwenI, SwinkI, Myntti M. The influence of anti-biofilm products on Osteogenesis and healing. Poster presented at American Academy of Orthopaedic Surgeons Annual Meeting. Chicago: IL, USA; 2022 March. p. 22–26.

[37] BattistaL, Wickline A. Beneficial effects of a novel intraoperative surgical irrigant on post-operative knee swelling and limb function in primary total knee arthroplasty. Journal of Orthopaedic Experience & Innovation. 2023 Dec.

[38] RenX, LingL, QiL, LiuZ, ZhangW, Yang Z, et al. Patients' risk factors for periprosthetic joint infection in primary total hip arthroplasty: a meta-analysis of 40 studies. BMC Musculoskelet Disord. 2021;22(1):776.

[39] WangQ, Goswami K, ShohatN, AalirezaieA, Manrique J, ParviziJ. Longer operative time results in a higher rate of subsequent periprosthetic joint infection in patients undergoing primary joint arthroplasty. J Arthroplasty. 2019;34(5):947–953.

[40] HrubinaM, NecasL, SammoudiD, Cabala J, LisyP, HoljencikJ, et al. Dynamic hip screw in proximal femoral fractures followed by “single-stage” hip arthroplasty-retrospective analysis. Eur J Orthopaedic Surg Traumatol Orthopedie Traumatol. 2024;34(2):1087–1093.

[41] KnappPW, ChenZ, ScuderiGR, Mont MA. Protocols for the use of a novel biofilm-disrupting wound irrigation solution for prevention of surgical-site infections after total joint arthroplasty. Surg Technol Int. 2021;39:405–411.

RIGHTS & PERMISSIONS

2024 2024 The Authors. Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.